Orchid Pharma's Alathur API Facility Successfully Completes USFDA Inspection
Orchid Pharma has successfully completed a surprise USFDA inspection at its Alathur API facility, securing its status as India’s only USFDA-approved site for Sterile Cephalosporins. The facility also secures EU GMP certificate renewal for Cephalosporin API manufacturing.
API Manufacturing | 20/02/2025 | By Abha
API Manufacturing | 19/09/2022 | By Sudeep Soparkar | 392
Bileshwar Pharma to set up API manufacturing unit in Dahej, Gujarat
The work is expected to commence by September 2024.
API Manufacturing | 06/09/2022 | By Sudeep Soparkar | 576
Flow reactor brings down costs drastically while significantly increasing safety in API Manufacturing
API Manufacturing | 23/08/2022 | By Sudeep Soparkar | 420
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy